Results 241 to 250 of about 499,895 (395)
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; GDMT, guideline‐directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection ...
Clara I. Saldarriaga+21 more
wiley +1 more source
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy With Midventricular Obstruction and Papillary Muscle Abnormalities. [PDF]
Sato R+4 more
europepmc +1 more source
A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy. [PDF]
Murtha CM, Dobson JR, Olinger AB.
europepmc +1 more source
Abstract Episodes of worsening heart failure (HF) are a major cause of unplanned hospitalizations. Their onset is usually preceded by an early increase in intracardiac pressures with subsequent worsening of symptoms due to congestion. Implantable devices allowing daily remote pulmonary artery pressure (PAP) monitoring are useful to identify early ...
Antoni Bayes‐Genis+13 more
wiley +1 more source
Longitudinal Outcomes of Left Ventricular Outflow Tract Obstruction in Aortic Stenosis Versus Hypertrophic Obstructive Cardiomyopathy. [PDF]
Ong JY+10 more
europepmc +1 more source
Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation. [PDF]
Hnátová H+4 more
europepmc +1 more source
Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy [PDF]
openaire +4 more sources
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo+22 more
wiley +1 more source